Please login to the form below

Not currently logged in


This page shows the latest mRNA-1273 news and features for those working in and with pharma, biotech and healthcare.

Moderna launches phase 1/2 study of mRNA-based flu vaccine

Moderna launches phase 1/2 study of mRNA-based flu vaccine

As a specialist in the mRNA field, Moderna has already found great success with its mRNA COVID-19 vaccine – mRNA-1273 – which was one of the first vaccines to be approved ... Respiratory combination vaccines are an important pillar of our overall

Latest news

More from news
Approximately 16 fully matching, plus 30 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Mednet Group

Communique Small consultancy of the year 2020. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Securing a future for telehealth with immersive market research insights...